Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.34 USD | +0.78% | +11.44% | -9.21% |
08/05 | Transcript : Arcus Biosciences, Inc., Q1 2024 Earnings Call, May 08, 2024 | |
08/05 | Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q1 Revenue $145M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.21% | 1.57B | |
+30.12% | 48.16B | |
-0.82% | 41.73B | |
+42.66% | 41.03B | |
-5.26% | 28.77B | |
+10.15% | 25.59B | |
-22.65% | 18.96B | |
+9.12% | 12.92B | |
+29.25% | 12.03B | |
-1.98% | 11.77B |
- Stock Market
- Equities
- RCUS Stock
- News Arcus Biosciences, Inc.
- Arcus Biosciences Says Phase 1b Study of Pancreatic Cancer Therapy Showed 'Promising Overall Survival Data'